
Sign up to save your podcasts
Or
In this very exciting bonus episode, we talk you through the recent headlines about declining U.S. overdose rates by detailing the seven major hypothesis people use to explain the rate drop. While the evidence supporting each of these hypotheses varies, it’s important to know what the current thinking is and why there is both cause to celebrate and to keep focusing on finding ways to continue the downward trend…until there are none.
Download the one-pager (PDF).
Balawajder, E. F., Ducharme, L., Taylor, B. G., Lamuda, P. A., Kolak, M., Friedmann, P. D., ... & Schneider, J. A. (2024). Factors associated with the availability of medications for opioid use disorder in US jails. JAMA Network Open,7(9), e2434704-e2434704. doi:10.1001/jamanetworkopen.2024.34704
This project was supported by Grant [5PBJA-22-AG-00031-MUMU] awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component of the Office of Justice Programs, which also includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, the Office for Victims of Crime, and Office of Sex Offender Sentencing, Monitoring, Apprehending, Registering, and Tracking. Points of view or opinions in this podcast are those of the host and the research team and do not necessarily represent the official position or policies of the U.S. Department of Justice.
In this very exciting bonus episode, we talk you through the recent headlines about declining U.S. overdose rates by detailing the seven major hypothesis people use to explain the rate drop. While the evidence supporting each of these hypotheses varies, it’s important to know what the current thinking is and why there is both cause to celebrate and to keep focusing on finding ways to continue the downward trend…until there are none.
Download the one-pager (PDF).
Balawajder, E. F., Ducharme, L., Taylor, B. G., Lamuda, P. A., Kolak, M., Friedmann, P. D., ... & Schneider, J. A. (2024). Factors associated with the availability of medications for opioid use disorder in US jails. JAMA Network Open,7(9), e2434704-e2434704. doi:10.1001/jamanetworkopen.2024.34704
This project was supported by Grant [5PBJA-22-AG-00031-MUMU] awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component of the Office of Justice Programs, which also includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, the Office for Victims of Crime, and Office of Sex Offender Sentencing, Monitoring, Apprehending, Registering, and Tracking. Points of view or opinions in this podcast are those of the host and the research team and do not necessarily represent the official position or policies of the U.S. Department of Justice.